ONCSM.E — Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapHigh Flyer

Market Cap
TRY3.81bn
Enterprise Value
TRY3.83bn
Revenue
TRY374.49m

Annual balance sheet for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	8.42	5.77	19.3	84.5	44.7
Net Total Accounts Receivable
Net Total Receivables	23.4	34.3	78.5	80.6	86.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	41.9	85.4	199	282	218
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	86.5	39.3	137	171	144
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	132	130	350	488	383
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	36	44.1	96.3	131	80.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	57.9	50.8	126	154	109
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	74.3	78.8	224	335	274
Total Liabilities & Shareholders' Equity	132	130	350	488	383
Total Common Shares Outstanding